ibusinesslines.com
ibusinesslines.com November 17, 2017


USA approves first pill with digital tracking device

14 November 2017, 08:08 | Melissa Porter

The sensor embedded in the pill sends information to the wearable patch that can be accessed on a phone or tablet. Proteus Digital Health

The sensor embedded in the pill sends information to the wearable patch that can be accessed on a phone or tablet.                  Proteus Digital Health

The Food and Drug Administration has approved for the first time a drug embedded with a digital sensor that can tell patients, caregivers and physicians when it has been taken. Approval of Abilify MyCite (aripiprazole tablets with sensor) comes as its manufacturer, Otsuka, is also marketing its once-a-month version of the therapy, which is approved for both schizophrenia and bipolar I disorder, 2 of the most debilitating mental health conditions.

"It is important to note that Abilify MyCite's prescribing information (labeling) notes that the ability of the product to improve patient compliance with their treatment regimen has not been shown", the FDA said in the November 13 statement.

Abilify MyCite's labeling information also notes the product's ability to improve treatment compliance in patients has not been proven.

Proteus has been working on the digital pill for years, and the tracking sensor was first approved for use by the FDA in 2012.

"Being able to track ingestion of medications prescribed for mental illness may be useful for some patients", said Dr. Mitchell Mathis, director of the division of psychiatry products in the FDA's Center for Drug Evaluation and Research, said in his statement on Abilify MyCite.


The sensor technology and patch are made by Proteus Digital Health, and are approved for use with existing medications in the United States and Europe.

Would you ingest a digital pill that allows you to conveniently track when you took the medication - and possibly allow others to track it as well? The system is meant to integrate into individuals' lives, and individuals indicate through the app which member (s) of their care team can access information about their medication ingestion, activity, and self-reported mood and rest. The hope is to provide additional clarity to better inform decision-making for physicians and their patients.

Should prescribes take to Abilify MyCite, the new formulation could help Abilify's maker Otsuka Pharmaceutical Co. Ltd.

According to Higuchi, the Abilify MyCite will be rolled out in phases to allow them to gather and respond to feedback provided by patients and health care providers.

The tracking system provides a way for doctors to objectively measure if patients are sticking to their medication schedules, opening doors for monitoring medicine intake methods in other areas of medicine and health care. Consumers already manage important tasks like banking, shopping, and communicating with friends and family by using their smartphones, as they go about their daily lives.



Other News

Trending Now

Tesco takeover of Booker gets all clear from independent authority
While 50% of Tesco investors must give the deal the green light, the threshold is 75% for Booker shareholders. The regulator is due to report its final findings in December.

EgyptAir to buy 12 Bombardier aircraft for $1.1 billion
At the Dubai Airshow on Tuesday, EgyptAir signed a letter of intent for 12 firm and 12 optional C Series CS300 aircraft. This includes firm orders for 12 CS300 aircraft with purchase rights for an additional 12 CS300s.

UCLA players in China shoplifting case could return to United States soon
Chinese authorities told the Post that the charges have been downgraded and the case against them is on a fast track toward resolution.

Wall Street Analysts Forecast 8.6% on Marathon Oil Corporation (NYSE:MRO)
Over a month, it has seen its stock price volatility to stay at 1.54% while shortening the period to a week, volatility was 1.85%. First Quadrant Limited Partnership Ca holds 0.62% of its portfolio in Marathon Petroleum Corp (NYSE:MPC) for 595,499 shares.

Polypipe Group PLC (PLP) Given Average Rating of "Buy" by Analysts
It fall, as 39 investors sold VTR shares while 204 reduced holdings. 18 funds opened positions while 46 raised stakes. Liberum Capital's target price per share gives a potential downside of -3.35% from the company's last close price.

BBB offers Black Friday shopping tips
Simply put, Black Friday does not have to be as hysterical as it usually is. "Deals will come and go through Christmas". That can mean the only way to benefit from the discount is if you are at the front of the lineup outside the store.

Bengaluru girl urges Modi to declare chronic type 1 diabetes a disability
World Diabetes Day became an official United Nations Day in 2006 with the passage of United Nation Resolution 61/225. In some instances as one ages, and the disease progresses, insulin injections may also be required.